Symptom Burden and Quality of Life in Multiple Myeloma: A Multicenter Study.

Authors

Jebrin Alkrinawi, Nizar Abu Hamdeh, Mohammad Alnees, Ibraheem AbuAlrub, Abdalaziz Darwish, Duha Najajra, Osama Ewidat, Yahya Z Fraitekh, Mohammad Masu Apos D, Omar Hammam Salloum, Reem J Saad, Nasim Abukaresh, Mustafa A Shahrori, Mahdi Awwad, Basem Bali, Nora I Baraghithi, Ahmad Alhashlamon, Yasmin Ahmad Rjoub, Mohammad Maswadeh, Zeina Sinnokrot, Firas Besharieh, Majde Abu Khaled, Rashed Saed, Rafufan Alsaied, Waed Awad, Nuha Riyad, Sarah Awad, Bashar Dawood, Yousef Abdelhay Yousef Abu Rayyan, Loay Shaheen, Majdi Khaled Zaid, Mohammed Manassra, Khairi Alzirei, Ali Abdullah, Haitham Abu Khadija

Published in

Oncology. Pages 1. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

Introduction Symptom burden is a critical determinant of treatment tolerance and survivorship in multiple myeloma (MM). We investigated how symptom severity and interference relate to patient-reported quality of life (QoL) across multiple domains in a multicenter real-world MM cohort. Methods This multicenter study included 250 previously treated patients with multiple myeloma recruited from six hospitals in the West Bank, Palestine.Symptom severity and interference were assessed at baseline using the MDASI-MM, and QoL was evaluated one month later with the FACT-MM. Multivariable linear regression adjusted for demographic and clinical covariates was applied. Results are reported as adjusted β coefficients with 95% confidence intervals, and a two-sided P<0.05 was considered statistically significant. Results Greater symptom burden was consistently associated with poorer quality of life. General, specific, and overall symptom severity showed the strongest associations with lower physical well-being, disease-specific concerns, pain-related quality of life, Trial Outcome Index, and FACT-MM total score. Specific symptoms were also associated with lower social well-being. Symptom interference domains showed similar but smaller associations, particularly with physical well-being, functional well-being, pain, and composite quality-of-life scores. Conclusion In this multicenter cohort of patients with multiple myeloma, higher symptom burden was consistently associated with poorer quality of life, especially in physical functioning, pain, and disease-specific concerns. Routine symptom monitoring may help identify patients who need early supportive care interventions.

PMID:
42842518
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.